Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

p53 anticorps

L’anticorps Souris Monoclonal anti-p53 a été validé pour WB, ELISA, FACS, IHC (p), IP et ICC. Il convient pour détecter p53 dans des échantillons de Humain et Non-Human Primate. Il y a 4+ publications disponibles.
N° du produit ABIN94448

Aperçu rapide pour p53 anticorps (ABIN94448)

Antigène

Voir toutes p53 (TP53) Anticorps
p53 (TP53) (Tumor Protein P53 (TP53))

Reactivité

  • 883
  • 271
  • 222
  • 136
  • 72
  • 71
  • 62
  • 38
  • 11
  • 10
  • 10
  • 7
  • 6
  • 3
  • 3
  • 3
  • 3
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
Humain, Non-Human Primate

Hôte

  • 644
  • 258
  • 5
  • 2
  • 2
Souris

Clonalité

  • 563
  • 347
  • 1
Monoclonal

Conjugué

  • 465
  • 46
  • 32
  • 20
  • 18
  • 14
  • 14
  • 14
  • 14
  • 14
  • 14
  • 14
  • 14
  • 14
  • 13
  • 13
  • 13
  • 13
  • 13
  • 13
  • 13
  • 13
  • 12
  • 12
  • 12
  • 12
  • 12
  • 11
  • 11
  • 10
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
Cet anticorp p53 est non-conjugé

Application

  • 680
  • 263
  • 247
  • 234
  • 194
  • 134
  • 129
  • 122
  • 111
  • 66
  • 65
  • 59
  • 35
  • 19
  • 17
  • 12
  • 10
  • 10
  • 8
  • 6
  • 4
  • 3
  • 3
  • 3
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Western Blotting (WB), ELISA, Flow Cytometry (FACS), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Immunoprecipitation (IP), Immunocytochemistry (ICC)

Clone

BP53-12
  • Fonction

    Anti-p53 Purified

    Specificité

    The antibody BP53-12 recognizes a defined epitope (aa 16-25) on human p53, a 50 kDa intracellular tumour suppressor found in increased amounts in a wide variety of transformed cells, it is frequently mutated or inactivated in many types of cancer.

    Réactivité croisée (Details)

    Human, Non-Human Primates

    Purification

    Purified by sequential steps of physicochemical fractionation (differential precipitation and solid-phase chromatography methods).

    Pureté

    > 95 % (by SDS-PAGE)

    Immunogène

    Bacterially expressed full-length wild-type p53

    Isotype

    IgG2a
  • Indications d'application

    Western blotting: Recommended dilution: 1-2 μg/mL, overnight at 4 °C, positive control: RAMOS human lymphoma cell line, non-reducing conditions. SDS-PAGE (12 % separating gel).
    Immunohistochemistry: Recommended dilution: 5-10 μg/mL.
    Flow cytometry: Recommended dilution: 1-4 μg/mL. Intracellular staining.

    Restrictions

    For Research Use only
  • Concentration

    1 mg/mL

    Buffer

    Phosphate buffered saline (PBS), pH 7.4, 15 mM sodium azide

    Agent conservateur

    Sodium azide

    Précaution d'utilisation

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Conseil sur la manipulation

    Do not freeze.

    Stock

    4 °C

    Stockage commentaire

    Store at 2-8°C. Do not freeze.
  • Yoshitake, Aoyagi, Fujiwara: "Creation of a novel telomere-cutting endonuclease based on the EN domain of telomere-specific non-long terminal repeat retrotransposon, TRAS1." dans: Mobile DNA, Vol. 1, Issue 1, pp. 13, (2010) (PubMed).

    Dolezalová, Vojt?sek, Kovarík: "Epitope analysis of the human p53 tumour suppressor protein." dans: Folia biologica, Vol. 43, Issue 1, pp. 49-51, (1997) (PubMed).

    Bártek, Bártková, Vojt?sek, Stasková, Lukás, Rejthar, Kovarík, Midgley, Gannon, Lane: "Aberrant expression of the p53 oncoprotein is a common feature of a wide spectrum of human malignancies." dans: Oncogene, Vol. 6, Issue 9, pp. 1699-703, (1991) (PubMed).

    Bártková, Bártek, Lukás, Vojt?sek, Stasková, Rejthar, Kovarík, Midgley, Lane: "p53 protein alterations in human testicular cancer including pre-invasive intratubular germ-cell neoplasia." dans: International journal of cancer. Journal international du cancer, Vol. 49, Issue 2, pp. 196-202, (1991) (PubMed).

  • Antigène

    p53 (TP53) (Tumor Protein P53 (TP53))

    Autre désignation

    p53

    Sujet

    Tumor protein p53,The tumour suppressor protein p53 is a key element of intracellular anticancer protection. It mediates cell cycle arrest or apoptosis in response to DNA damage or to starvation for pyrimidine nukleotides. It is up-regulated in response to these stress signals and stimulated to activate transcription of specific genes, resulting in expression of p21waf1 and other proteins involved in G1 or G2/M arrest, or proteins that trigger apoptosis, such as Bcl-2. The structure of p53 comprises N-terminal transactivation domain, central DNA-binding domain, oligomerisation domain, and C-terminal regulatory domain. There are various phosphorylation sites on p53, of which the phosphorylation at Ser15 is important for p53 activation and stabilization.,BCC7, TRP53, TP53, LFS1

    ID gène

    7157

    UniProt

    P04637

    Pathways

    Signalisation p53, Signalisation MAPK, Signalisation PI3K-Akt, Apoptose, AMPK Signaling, Chromatin Binding, ER-Nucleus Signaling, Positive Regulation of Endopeptidase Activity, Hepatitis C, Protein targeting to Nucleus, Autophagy, L'effet Warburg
Vous êtes ici:
Chat with us!